Cardiomodulatory Effects of Gender-Affirming Hormone Therapy
NCT07128771
·
clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
450
Enrollment
OTHER
Sponsor class
Conditions
Gender Incongruence
Cardiovascular Disease (CVD) Risk Factors
Sponsor
University Hospital, Akershus
Collaborators
[object Object]
[object Object]